Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Although evolocumab and alirocumab lowered low-density lipoprotein better than statins, evidence of cardiovascular benefit had been lacking — until now.</p>

PCSK9 Drug Improves Heart Outcomes